BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35884402)

  • 1. Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells.
    Crook T; Leonard R; Mokbel K; Thompson A; Michell M; Page R; Vaid A; Mehrotra R; Ranade A; Limaye S; Patil D; Akolkar D; Datta V; Fulmali P; Apurwa S; Schuster S; Srinivasan A; Datar R
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.
    Limaye S; Chowdhury S; Rohatgi N; Ranade A; Syed N; Riedemann J; Patil D; Akolkar D; Datta V; Patel S; Chougule R; Shejwalkar P; Bendale K; Apurwa S; Schuster S; John J; Srinivasan A; Datar R
    Cancer Med; 2023 Apr; 12(8):9116-9127. PubMed ID: 36718027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters.
    Gaya A; Rohatgi N; Limaye S; Shreenivas A; Ajami R; Akolkar D; Datta V; Srinivasan A; Patil D
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
    Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
    Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.
    Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: the BEST (Breast Early Screening Test) study.
    Murray NP; Miranda R; Ruiz A; Droguett E
    Asian Pac J Cancer Prev; 2015; 16(5):1929-34. PubMed ID: 25773847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.
    Ning N; Zhan T; Zhang Y; Chen Q; Feng F; Yang Z; Liu Z; Xu D; Wang F; Guo Y; Xing J; Guan Y; Cui W
    Clin Chim Acta; 2014 Jun; 433():69-75. PubMed ID: 24607330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
    Jia M; Mao Y; Wu C; Wang S; Zhang H
    Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancer.
    Farhang Ghahremani M; Seto KKY; Cho W; Miller MC; Smith P; Englert DF
    J Transl Med; 2023 Jun; 21(1):414. PubMed ID: 37365600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
    PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
    Adams DL; Adams DK; Alpaugh RK; Cristofanilli M; Martin SS; Chumsri S; Tang CM; Marks JR
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1037-42. PubMed ID: 27197300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer.
    Molloy TJ; Devriese LA; Helgason HH; Bosma AJ; Hauptmann M; Voest EE; Schellens JH; van't Veer LJ
    Br J Cancer; 2011 Jun; 104(12):1913-9. PubMed ID: 21587256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.